| [1] |
James MT, Quan H, Tonelli M, et al. CKD and risk of hospilization and death with pneumonia [J]. Am J Kidney Dis, 2009, 54(1): 24-32.
|
| [2] |
Saran R, Li Y, Robinson B, et al. US Renal Data System 2015 annual data report: epidemiology of kidney disease in the United States [J]. Am J Kidney Dis, 2016, 67(3 Suppl 1): S1-S305.
|
| [3] |
Ishigami J, Grams ME, Chang AR, et al. CKD and risk for hospitalization with infection: the atherosclerosis risk in communities (ARIC) study [J]. Am J Kidney Dis, 2017, 69(6): 752-761.
|
| [4] |
James MT, Laupland KB, Tonelli M, et al. Risk of bloodstream infection in patients with chronic kidney disease not treated with dialysis [J]. Arch Intern Med, 2008, 168(21): 2333-2339.
|
| [5] |
Sarnak MJ, Jaher BL. Mortality caused by sepsis in patients with end stage renal disease compared with the general population [J]. Kidney Int, 2000, 58(4): 1758-1764.
|
| [6] |
Slinin Y, Foley RN, Collins AJ. Clinical epidemiology of pneumonia in hemodialysis patients: the USRDS waves 1, 3, and 4 study [J]. Kidney Int, 2006, 70(6): 1135-1141.
|
| [7] |
Centers for Disease Control and Prevention (CDC). Invasive methicillin-resistant Staphylococcus aureus infections among dialysis patients--United States, 2005 [J]. MMWR Morb Mortal Wkly Rep, 2007, 56(9): 197-199.
|
| [8] |
Hussein MM, Mooi J JM, Roujouleh H. Tuberculosis and chronic renal disease [J]. Semin Dial，2003，16(1): 38-44.
|
| [9] |
Kita H, Abu-Ghazaleh R, Sanderson CJ, et al. Effect of steroids on immunoglobulin-induced eosinophil degranulation [J]. J Allergy Clin Immunol, 1991, 87(1): 70-77.
|
| [10] |
Ishigami J, Matsushita K. Clinical epidemiology of infectious disease among patients with chronic kidney disease [J]. Clin Exp Nephrol, 2019, 23(4): 437-447.
|
| [11] |
Loechelt BJ, Green M, Gottlieb PA, et al. Screening and monitoring for infectious complications when immunosuppressive agents are studied in the treatment of autoimmune disorders [J]. J Pediatric Infect Dis Soc, 2015, 4(3): 198-204.
|
| [12] |
Wei CC, Yu IW, Lin HW. Occurrence of nfection among children with nephrotic syndrome during hospitalizations [J]. Nephrology (Carlton), 2012, 17(8): 681-688.
|
| [13] |
Li J, Zhang Q, Su B. Clinical characteristics and risk factors of severe infection in hospitalized adult patients with primary nephrotic syndrome [J]. J Int Med Res, 2017, 45(6): 2139-2145.
|
| [14] |
Yang CY, Yang WC, Lin CC. Risk factors for Pneumocystis jiroveci pneumonia in glomerulonephritis patients receiving immunosuppressants [J]. Intern Med, 2012, 51(20): 2869-2875.
|
| [15] |
Guo F, Chen Y, Yang SL, et al. Pneumocystis pneumonia in HIV-infected and immunocompromised non-HIV infected patients: a retrospective study of two centers in China [J]. PLoS One, 2014, 9(7): e101943.
|
| [16] |
Yale SH, Limper AH. Pneumocystis carinii pneumonia in patients without acquired immunodeficiency syndrome: associated illness and prior corticosteroid therapy [J]. Mayo Clin Proc, 1996, 71(1): 5-13.
|
| [17] |
Rodriguez M, Fishman JA. Prevention of infection due to Pneumocystis spp. in human immunodeficiency virus-negative immunocompromised patients [J]. Clin Microbiol Rev, 2004, 17(4): 770-782.
|
| [18] |
Ye WL, Tang N, Wen YB, et al. Underlying renal insufficiency: the pivotal risk factor？for Pneumocystis jiroveci pneumonia in immunosuppressed patients with non-transplant glomerular disease [J]. Int Urol Nephrol, 2016, 48(11): 1863-1871.
|
| [19] |
Roblot F, Le Moal G, Kauffmann-Lacroix C, et al. Pneumocystis jirovecii pneumonia in HIV-negative patients: a prospective study with focus on immunosuppressive drugs and markers of immune impairment [J]. Scand J Infect Dis, 2014, 46(3): 210-214.
|
| [20] |
Esteves F, Calé SS, Badura R，et a1. Diagnosis of Pneumocystis pneumonia: evaluation of four serologic biomarkers [J]. Clin Microbiol Infect, 2015, 21(4): e1-e10.
|
| [21] |
Nakamura H, Tateyama M, Tasato D, et a1. Clinical utility of serum beta-D-glucan and KL-L levels in Pneumocystis jirovecii pneumonia [J]. Intern Med, 2009, 48(4): 195-202.
|
| [22] |
Sepkowitz KA. Pneumocystis carinii pneumonia without acquired immunodeficiency syndrome: who should receive prophylaxis? [J]. Mayo Clin Proc, 1996, 71(1): 102-103.
|
| [23] |
Kotton CN, Kumar D, Caliendo AM. et al. The third international consensus guidelines on the management of cytomegalovirus in solid-organ transplantation [J]. Transplantation, 2018, 102(6): 900-931.
|
| [24] |
Kotton CN, Kumar D, Caliendo AM, et al. Transplantation Society International CMV Consensus Group. Updated international consensus guidelines on the management of cytomegalovirus in solid-organ transplantation [J]. Transplantation, 2013, 96(4): 333-360.
|
| [25] |
Lederman ER, Crum NF. A case series and focused review of nocardiosis: clinical and microbiologic aspects [J]. Medicine (Baltimore), 2004, 83(5): 300-313.
|
| [26] |
郭锦洲，许书添，姜玲，等．肾病综合征患者合并播散性奴卡菌感染的临床特征[J]．肾脏病与透析肾移植杂志，2016，25(3):245-250.
|
| [27] |
Cercenado E, Marín M, Sánchez-Martínez M, et al. In vitro activities of tigecycline and eight other antimicrobials against different Nocardia species identified by molecular methods [J]. Antimicrob Agents Chemother, 2007, 51(3): 1102-1104.
|
| [28] |
Internal Clinical Guidelines Team (UK). Tuberculosis: prevention, diagnosis, management and service organization [M]. London: National Institute for Health and Care Excellence (UK), 2016.
|
| [29] |
Nakamura H, Tateyama M, Tasato D. Active tuberculosis in patients undergoing hemodialysis for end-stage renal disease: a 9-year retrospective analysis in a single center [J]. Inter Med, 2009, 48(24): 2061-2067.
|
| [30] |
Rogerson TE, Chen S, Kok J, et al. Tests for latent tuberculosis in people with ESRD: a systematic review [J]. Am J Kidney Dis, 2013, 61(1): 33-43.
|
| [31] |
Redelman-Sidi G, Sepkowitz KA. IFN-γ release assays in the diagnosis of latent tuberculosis infection among immunocompromised adults [J]. Am J Respir Crit Care Med, 2013, 188(4): 422-431.
|
| [32] |
Ribeiro S, Dooley K, Hackman J, et al. T-SPOT.TB responses during treatment of pulmonary tuberculosis [J]. BMC Infect Dis, 2009, 9: 23.
|
| [33] |
Latorre I, De Souza-Galvao M, Ruiz-Manzano J, et al. Quantitative evaluation of T-cell response after specific antigen stimulation in active and latent tuberculosis infection in adults and children [J]. Diagn Microbiol Infect Dis, 2009, 65(3): 236-246.
|
| [34] |
Meije Y, Piersimoni C, Torre-Cisneros J, et al. Mycobacterial infections in solid organ transplant recipients [J]. Clin Microbiol Infect, 2014, 20(Suppl 7): 89-101.
|
| [35] |
Madhi SA, Nachman S, Violari A, et al. Primary isoniazid prophylaxis against tuberculosis in HIV-exposed children [J]. N Engl J Med, 2011, 365(1): 21-31.
|
| [36] |
Wang H, Wang S, Xu L, et al. Application of T．SPOT-TB assay for early diagnosis of active tuberculosis in chronic kidney disease patients receiving immunosuppressive treatment [J]. J Invest Surg, 2019, published online ahead of print.
|
| [37] |
田际云，梅建，高谦. 结核分枝杆菌潜伏感染的预防治疗及面临的问题[J]．中华结核和呼吸杂志，2016，39(1):8-11.
|